Abstract
To investigate the effect of the eradication ofHelicobacter pylori on the healing and relapse of duodenal ulcers. 50 patients with active duodenal ulcer andH. pylori infection were randomly allocated to two treatment groups. One group (cimetidine group) received cimetidine 400mg twice daily for 6 weeks and the other group (double-therapy group) received 300mg amoxicillin granules and 250 mg metronidazole thrice daily for 2 weeks, in addition to the same regimen of cimetidine as the cimetidine group. Forty-two patients completed the study. After confirmation of ulcer scar, all patients were followed up for 6 months while receiving treatment with teprenone, an agent that does not affect acid secretion or the eradication ofH. pylori. The healing rates at 6 weeks were 90% in the cimetidine group and 95.5% in the double-therapy group.H. pylori eradication occurred in 0% of the cimetidine group and in 73.7% of the double-therapy group (P-0.004). The cumulative relapse rates in the two groups at 6 months were 64.3% and 11.1%, respectively (P=0.0007). In the double-therapy group, the cumulative relapse rate at 6 months in the patients in whomH. pylori persisted was 50% (2/4); the rate was 0% (0/14) in the patients in whomH. pylori had been eradicated (P=0.005). Histological gastritis significantly improved compared with the baseline in the double-therapy group, but no such improvement was seen in the cimetidine group. White scarring was found in 7.1% of the cimetidine group and in 83.3% of the double-therapy group after 6 months (P=0.0001). The eradication ofH. pylori markedly decreased the relapse rate in duodenal ulcer patients, and it significantly improved both the grade of gastritis and the quality of the ulcer scar.
Similar content being viewed by others
References
Marshall BJ, Goodwin CS, Warren JR, et al. Prospective doubleblind trial of duodenal ulcer relapse after eradication ofCampylobacter pylori. Lancet 1988;II:1437–1442.
Coghlan JG, Gilligan D, Humphries H, et al.Campylobacter pylori and recurrence of duodenal ulcers—A 12-month follow-up study. Lancet 1987;II:1109–1111.
Graham DY, Lew GM, Klein PD, et al. Effect of treatment ofHelicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705–708.
Unge P, Gad A, Eriksson K, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325–331.
Massarrat S, Dehbashi N, Salari S. et al. Comparison of two treatment regimens (4 weeks ranitidine versus 2 weeks bismuth and tetracycline followed by 2 weeks metronidazole) for acute duodenal ulcer and ulcer relapse. Eur J Gastroenterol Hepatol 1992;4:877–880.
Mames GA, Bayerdörffer E, Höchter W, et al. Decreased relapse rate after antibacterial treatment ofHelicobacter pylori-associated duodenal ulcers. Munich duodenal ulcer trial. Eur J Gastroenterol Hepatol 1993;5:145–153.
Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication ofHelicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308–312.
Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet 1990;335:1233–1235.
Graham DY, Lew GM, Evans DG, et al. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. Ann Intern Med 1991;115:266–269.
Kohli Y, Kato T, Ito S, et al. Significance ofHelicobacter pylori infection in human peptic ulcer. Dig Endose 1993;5:43–48.
Uemura N, Okamoto S, Mukai T, et al. The role of eradication ofHelicobacter pylori in healing and recurrence of peptic ulcer. In: Proc of the 7th international symposium onHelicobacter pylori and its disease. April 18–19, 1994, Tokyo, Abstract p28.
Sakita T, Fukutomi T. Endoscopic diagnosis (in Japanese). In: Yoshitosi Y (ed) Ulcers of stomach and duodenum. Tokyo: Nankodo 1971;197–208.
Miyake T, Suzuki T, Oishi M. Correlation of gastric ulcer healing features of endoscopy, stereoscopic microscopy, and histology, and a reclassification of the epithelial regenerative process. Dig Dis Sci 1980;25:8–14.
Paoluzi P, Ricotta G, Ripoli F, et al. Incompletely and completely healed duodenal ulcers' outcome in maintenance treatment: A double blind controlled study. Gut 1985;26:1080–1085.
Okada M, Yao T, Maeda K, et al. Predictors of duodenal ulcer healing during treatment with cimetidine. Gut 1990;31:758–762.
Terano A, Shiga J, Hiraishi H, et al. Protective action of tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. Digestion 1986;35:182–188.
Arakawa T, Yamada H, Nakamura A, et al. Gastric cytoprotection by tetraprenylacetone in human subjects. Digestion 1988; 39:111–117.
Narikawa S, Yanagawa A, Hori S, et al. Effect of anti-ulcer terpenes and some antimicrobial agents on the growth ofHelicobacter pylori (in Japanese). Jpn J Inflammation 1992;12:343–347.
Fukami T. Isolation, identification ofCampylobacter pylori (in Japanese) Examination and Technology 1989;17:1389–1394.
Spinzi GC, Sangioranni A, Imperiali G, et al. Prevention of duodenal ulcer relapse with amoxicillin and omeprazole. Eur J Gastroenterol Hepathol 1994;6:599–602.
Marshall BJ, Armstrong JA, Francis GJ, et al. Antibacterial action of bismuth in relation toCampylobacter pyloridis colonization and gastritis. Digestion 1987;37[Suppl 2]:16–30.
Rugge M, Mario FDI, Cassaro M, et al. Pathology of the gastric antrum and body associated withHelicobacter pylori infection in non-ulcerous patients: Is the bacterium a promoter of intestinal metaplasia? Histopathology 1993;22:9–15.
Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication ofHelicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet 1994;343:508–510.
Bayerdörffer E, Mannes GA, Sommer A, et al. High-dose omeprazole treatment combined with amoxicillin eradicatesHelicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697–702.
Boixeda D, Rafael LD, Cantón R, et al. Galenical formulations of amoxicillin/clavulanate and eradication ofHelicobacter pylori in peptic ulcer patients: Preliminary report. Eur J Gastroenterol Hepatol 1993;5:283–285.
Chiba N, Rao BV, Rademaker JW, et al. Meta-analysis of the efficacy of antibiotic therapy in eradicatingHelicobacter pylori. Am J Gastroenterol 1992;87:1716–1727.
Rauws EAJ, Langenberg W, Houthoff HJ, et al.Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988;94:33–40.
Stolte M, Eidt S, Ohnsmann A. Differences inHelicobacter pylori-associated gastritis in the antrum and body of the stomach. Z Gastroenterol 1990;28:229–233.
Louw JA, Falck V, Rensbesg CV, et al. Distribution ofHelicobacter pylori colonization and associated gastric inflammatory change: Difference between patients with duodenal and gastric ulcers. J Clin Pathol 1993;46:754–756.
Tytgat GNJ, Dixon MF.Helicobacter pylori infection: Role in peptic ulcer disease. In: Northfield TC, Memdal M, Goggin PM (eds)Helicobacter pylori infection—Pathophysiology, epidemiology and management, London: Kluwer Academic, 1993;75–87.
Nishimaki T, Watanabe H, Muto T. Histological findings on the clinically healing state of gastric ulcers (in Japanese with English abstract). Stomach Intest 1984;19:993–999.
Miyake T, Ariyoshi J, Suzuki T, et al. Endoscopic evaluation of the effects of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers. Dig Dis Sci 1980;25:1–7.
Takemoto T, Namiki M, Ishikawa M, et al. Ranitidine and sucralfate as maintenance therapy for gastric ulcer disease: Endoscopic control and assessment of scarring. Gut 1989;30: 1692–1697.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shirotani, T., Okada, M., Murayama, H. et al. Effect of the eradication ofHelicobacter pylori on duodenal ulcer healing and ulcer relapse: Randomized controlled study in Japan. J Gastroenterol 31, 175–181 (1996). https://doi.org/10.1007/BF02389515
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02389515